z-logo
open-access-imgOpen Access
Genetics and pharmacogenetics of mood disorders
Author(s) -
Alessandro Serretti
Publication year - 2017
Publication title -
psychiatria polska
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.414
H-Index - 22
eISSN - 2391-5854
pISSN - 0033-2674
DOI - 10.12740/pp/68914
Subject(s) - pharmacogenetics , mood disorders , medicine , genetics , bioinformatics , psychiatry , genotype , biology , gene , anxiety
Genetic research in Psychiatry is viewed by clinicians with both hope and curiosity sometimes mixed with disillusionment. Indeed, in the last 30 years many results have not been confirmed and clinical applications are still missing. However recent findings suggest that we are at the beginning of a new era. A set of variants within neuroplasticity and inflammation genes have been identified as a valid basis for both bipolar disorder and major depression. Similarly, a set of genes has been identified as a liability factor for response and tolerability to antidepressants and the first clinical applications are already in the market. However, some caution should be applied until definite findings are available.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom